Analysis of leukemia cells isolated from PC, PB and spleen after 2 weeks of treatment showed a significantly greater increase in NFKBIE MAF in mice treated with ibrutinib compared to control mice in all investigated compartments (Fig. 7C). The gene discussed is NFKBIE; the disease is leukemia.